INVO Bioscience is a commercial-stage fertility company focused on the expansion of the assisted reproductive technology marketplace through its flagship product, according to a Jan. 3 news release from the company. The INVOCell is a medical device designed to allow fertilization and early embryo development to take place in vivo within a patient’s body.
Dr. Holmström joins INVO with more than two decades of experience as a gynecologist. She most recently served as a professor in obstetrics and gynecology at the University of South Florida Morsani College of Medicine in Tampa.
She also led a full-time academic practice at USF Physicians Group for 18 years while at USF, the release said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
